Small-colony variants: A novel mechanism for triclosan resistance in methicillin-resistant Staphylococcus aureus

Journal of Antimicrobial Chemotherapy

Volumn 59, Issue 1, 2007, Pages 43-50

  Seaman, Paul F ^a   Ochs, Dietmar ^b   Day, Martin J ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b Ciba Grenzach GmbH   (Germany)

Author keywords

Atypical growth; Biocide resistance; Co resistance; Mechanisms of resistance

Indexed keywords

CETYLPYRIDINIUM SALT; CHLORAMPHENICOL; CHLORHEXIDINE GLUCONATE; CIPROFLOXACIN; ERYTHROMYCIN; GENTAMICIN; LINEZOLID; METICILLIN; OXACILLIN; PENICILLIN G; PSEUDOMONIC ACID; TEICOPLANIN; TETRACYCLINE; TRICLOSAN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL GENETICS; BACTERIAL GROWTH; BACTERIAL MUTATION; BACTERIAL SURVIVAL; BACTERIUM ISOLATION; BACTERIUM MUTANT; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG INDICATION; DRUG TOLERANCE; DRUG TREATMENT FAILURE; GENE MUTATION; GENE SEQUENCE; IN VITRO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE;

ANTI-INFECTIVE AGENTS, LOCAL; CULTURE MEDIA; DRUG RESISTANCE, BACTERIAL; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCUS AUREUS; TRICLOSAN;

EID: 33845904111     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkl450     Document Type: Article

References (42)

1. Proctor RA, von Eiff C, Kahl BC et al. Small colony variants: A pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat Rev Microbiol 2006; 4: 295-305.
2. Proctor RA, van Langevelde P, Kristjansson M et al. Persistent and relapsing infections associated with small-colony variants of Staphylococcus aureus. Clin Infect Dis 1995; 20: 95-102.
3. Spanu T, Romano L, D'Inzeo T et al. Recurrent ventriculoperitoneal shunt infection caused by small-colony variants of Staphylococcus aureus. Clin Infect Dis 2005; 41: E48-52.
4. Kahl B, Herrmann M, Everding AS et al. Persistent infection with small colony variant strains of Staphylococcus aureus in patients with cystic fibrosis. J Infect Dis 1998; 177: 1023-9.
5. Jonsson I-M, von Eiff C, Proctor RA et al. Virulence of a hemB mutant displaying the phenotype of a Staphylococcus aureus small colony variant in a murine model of septic arthritis. Microb Pathog 2003; 34: 73-9.
6. Seifert H, von Eiff C, Fatkenheuer G. Fatal case due to methicillin-resistant Staphylococcus aureus small colony variants in an AIDS patient. Emerg Infect Dis 1999; 5: 450-3.
7. Pelletier LL Jr, Richardson M, Feist M. Virulent gentamicin-induced small colony variants of Staphylococcus aureus. J Lab Clin Med 1979; 94: 324-34.
8. McNamara PJ, Proctor RA. Staphylococcus aureus small colony variants, electron transport and persistent infections. Int J Antimicrob Agents 2000; 14: 117-22.
9. Livermore DM. Antibiotic resistance in staphylococci. Int J Antimicrob Agents 2001; 16: 3-10.
10. Kuroda M, Ohta T, Uchiyama I et al. Whole genome sequencing of methicillin-resistant Staphylococcus aureus. Lancet 2001; 357: 1225-40.
11. Gilman S, Saunders VA. Accumulation of gentamicin by Staphylococcus aureus: The role of the transmembrane electrical potential. J Antimicrob Chemother 1986; 17: 37-44.
12. Massey RC, Buckling A, Peacock SJ. Phenotypic switching of antibiotic resistance circumvents permanent costs in Staphylococcus aureus. Curr Biol 2001; 11: 1810-14.
13. Russell AD. Whither triclosan? J Antimicrob Chemother 2004; 53: 693-5.
14. Ayliffe GA, Buckles A, Casewell MW et al. Revised guidelines for the control of methicillin-resistant Staphylococcus aureus infection in hospitals. J Hosp Infect 1998; 39: 253-90.
15. Zafar AB, Butler RC, Reese DJ et al. Use of 0.3% triclosan (Bacti-Stat) to eradicate an outbreak of methicillin-resistant Staphylococcus aureus in a neonatal nursery. Am J Infect Control 1995; 23: 200-8.
16. Brady LM, Thomson M, Palmer MA et al. Successful control of endemic MRSA in a cardiothoracic surgical unit. Med J Aust 1990; 152: 240-5.
17. Webster J, Faoagali JL, Cartwright D. Elimination of methicillin-resistant Staphylococcus aureus from a neonatal intensive care unit after hand washing with triclosan. J Paediatr Child Health 1994; 30: 59-64.
18. Coia JE, Duckworth GJ, Edwards DI et al. Guidelines for the control and prevention of methicillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities. J Hosp Infect 2006; 63: 1-44.
19. Cookson BD, Farrelly H, Stapleton P et al. Transferable resistance to triclosan in MRSA. Lancet 1991; 337: 1548-9.
20. Russell AD. Mechanisms of antimicrobial action of antiseptics and disinfectants: An increasingly important area of investigation. J Antimicrob Chemother 2002; 49: 597-9.
21. Suller MT, Russell AD. Triclosan and antibiotic resistance in Staphylococcus aureus. J Antimicrob Chemother 2000; 46: 11-18.
22. Villalain J, Mateo CR, Aranda FJ et al. Membranotropic effects of the antibacterial agent triclosan. Arch Biochem Biophys 2001; 390: 128-36.
23. McDonnell G, Pretzer D. Action and targets of triclosan. ASM News 1998; 84: 670-1.
24. Heath RJ, Rock CO. A triclosan-resistant bacterial enzyme. Nature 2000; 406: 145-6.
25. Levy CW, Roujeinikova A, Sedelnikova S et al. Molecular basis of triclosan activity. Nature 1999; 398: 383-4.
26. McMurry LM, Oethinger M, Levy SB. Triclosan targets lipid synthesis. Nature 1998; 394: 531-2.
27. Ledder RG, Gilbert P, Willis C et al. Effects of chronic triclosan exposure upon the antimicrobial susceptibility of 40 ex-situ environmental and human isolates. J Appl Microbiol 2006; 100: 1132-40.
28. McBain AJ, Bartolo RG, Catrenich CE et al. Effects of triclosan-containing rinse on the dynamics and antimicrobial susceptibility of in vitro plaque ecosystems. Antimicrob Agents Chemother 2003; 47: 3531-8.
29. McBain AJ, Bartolo RG, Catrenich CE et al. Exposure of sink drain microcosms to triclosan: Population dynamics and antimicrobial susceptibility. Appl Environ Microbiol 2003; 69: 5433-42.
30. Cole EC, Addison RM, Rubino JR et al. Investigation of antibiotic and antibacterial agent cross-resistance in target bacteria from homes of antibacterial product users and nonusers. J Appl Microbiol 2003; 95: 664-76.
31. Heatley NG. A method for the assay of penicillin. Biochem J 1944; 38: 61-5.
32. Zhang K, Sparling J, Chow BL et al. New quadriplex PCR assay for detection of methicillin and mupirocin resistance and simultaneous discrimination of Staphylococcus aureus from coagulase-negative staphylococci. J Clin Microbiol 2004; 42: 4947-55.
33. von Eiff C, Heilmann C, Proctor RA et al. A site-directed Staphylococcus aureus hemB mutant is a small-colony variant which persists intracellularly. J Bact 1997; 179: 4706-12.
34. Andrews JM. Determination of minimum inhibitory concentrations. J Antimicrob Chemother 2001; 48: 5-16.
35. Gomez Escalada M, Russell AD, Maillard JY et al. Triclosan-bacteria interactions: Single or multiple target sites? Lett Appl Microbiol 2005; 41: 476-81.
36. Walsh SE, Maillard JY, Russell AD. Ortho-phthalaldehyde: A possible alternative to glutaraldehyde for high level disinfection. J Appl Microbiol 1999; 86: 1039-46.
37. Langsrud S, Sundheim G. Factors influencing a suspension test method for antimicrobial activity of disinfectants. J Appl Microbiol 1998; 85: 1006-12.
38. Enright MC, Day NPJ, Davies CE et al. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol 2000; 38: 1008-15.
39. Slater-Radosti C, Van Aller G, Greenwood R et al. Biochemical and genetic characterization of the action of triclosan on Staphylococcus aureus. J Antimicrob Chemother 2001; 48: 1-6.
40. Kahl BC, Belling G, Reichelt R et al. Thymidine-dependent small-colony variants of Staphylococcus aureus exhibit gross morphological and ultrastructural changes consistent with impaired cell separation. J Clin Microbiol 2003; 41: 410-13.
41. Vesga O, Groeschel MC, Otten MF et al. Staphylococcus aureus small colony variants are induced by the endothelial cell intracellular milieu. J Infect Dis 1996; 173: 739-42.
42. Barcia-Macay M, Seral C, Mingeot-Leclercq M-P et al. Pharmacodynamic evaluation of the intracellular activities of antibiotics against Staphylococcus aureus in a model of THP-1 macrophages. Antimicrob Agents Chemother 2006; 50: 841-51.